Tom Gallen

Tom Gallen

Managing Editor, Europe

Birmingham, UK

Tom reports and edits European consumer health care industry news and analysis. Leading HBW Insight’s health and wellness coverage in Europe, he has been writing about the sector since 2013. Tom’s main focus is analyzing the strategies of the world's leading consumer healthcare companies, their business performance, plans and product portfolios. He also reports on regulatory topics such as novel foods and prescription-to-OTC switches.

Latest from Tom Gallen

Haleon Talks Up China Strength As Investment Grows

Haleon highlighted consistent market share gains in China as it reported third-quarter results.

Magnesium Brain Health Supplement Sold Across US Authorized As Novel Food In EU

Dietary supplement ingredient promising enhanced memory and mental clarity marketed widely across the US has been authorized for sale in Europe.

Help Or Hindrance To Food Supplement Innovation? Experts Assess New EU Novel Food Guidance

EFSA has published new guidance to assist companies navigating the EU’s novel food authorisation process. HBW Insight speaks to experts Dr Mari Eskola of Medfiles and Dr Jérôme Le Bloch of FoodChain ID who offer differing views on the benefits and drawbacks of the guidance for industry.

Sanofi Clarifies Bpifrance's Role In Opella Deal

French public sector investment bank Bpifrance's influence over the future strategy of Opella extends to its one seat on the company's board, but not past that, Sanofi confirms as it reports Q3 results.

Reckitt Promises ‘Big’ Q4 As Consumer Health Market Share Rebounds

A better than expected showing from its Health business in its latest quarter has teed up Reckitt for a big finish to the year.

Shortlist Revealed For OTC Marketing Awards 2024

The nominations are out for this year's OTC Marketing Awards, which takes place on Thursday 21 November at the Royal Lancaster London.